Overview

Crossover Clinical Trial, Randomized, Double Blind, Placebo Controlled Trial

Status:
Completed
Trial end date:
2016-04-29
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of inhibiting xanthine oxidase with allopurinol in patients with chronic kidney disease in asymptomatic hyperuricemia endothelial injury and vascular repair mechanisms.
Phase:
Phase 2
Details
Lead Sponsor:
Maimónides Biomedical Research Institute of Córdoba
Treatments:
Allopurinol